FDA clears Microvena's Clot Buster:
This article was originally published in Clinica
Executive Summary
Microvena's Clot Buster amplatz thrombectomy device has been cleared by the US FDA. This clot-dissolving device is used to treat dialysis patients suffering from kidney disease who might otherwise undergo surgery or intravenous drug therapy for clot removal. Clot Buster liquefies clots by creating a vortex action. The company, which is based in White Bear Lake, Minnesota, says its device is now available worldwide having already received CE-marking in Europe.